After launching noodles and personal care brands, and taking on giants like Nestle, Colgate Palmolive and HUL, Patanjali now plans its own version of GlaxoSmithKline’s Horlicks, report’s The Times of India.
GSK lacklustre performance in the January-March 2016 quarter has raised questions about whether it can withstand Patanjali’s foray.
The Patanjali product though, is 5 percent more expensive than Horlicks.
In the past few months, Patanjali has emerged as a strong competitor to Nestle’s Maggi in the instant noodles segment and to Colgate in the toothpaste segment.
However, Patanjali also fell into deep trouble early this year after a team of Food Safety and Drugs Administration (FSDA) had found a Patanjali Atta Noodles sample “sub-standard.”
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)